Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate in the IBIS-II bone substudy: an international, double-blind, randomised, placebo-controlled trial
Open Access
- 1 December 2014
- journal article
- research article
- Published by Elsevier in The Lancet Oncology
- Vol. 15 (13) , 1460-1468
Abstract
No abstract availableKeywords
Funding Information
- Cancer Research UK (C569/A5032)
- National Health and Medical research Council Australia (GNT300755, GNT569213)
This publication has 30 references indexed in Scilit:
- Amount of Bone Loss in Relation to Time around the Final Menstrual Period and Follicle-Stimulating Hormone Staging of the TransmenopauseThe Journal of Clinical Endocrinology & Metabolism, 2010
- Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trialAnnals of Oncology, 2009
- Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230Journal of Clinical Oncology, 2008
- Bone Loss and Fracture Risk Associated with Cancer TherapyThe Oncologist, 2006
- Effect of Letrozole Versus Placebo on Bone Mineral Density in Women With Primary Breast Cancer Completing 5 or More Years of Adjuvant Tamoxifen: A Companion Study to NCIC CTG MA.17Journal of Clinical Oncology, 2006
- Effect of an Aromatase Inhibitor on BMD and Bone Turnover Markers: 2-Year Results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) Trial (18233230)Journal of Bone and Mineral Research, 2006
- Effects of Exemestane Administered for 2 Years Versus Placebo on Bone Mineral Density, Bone Biomarkers, and Plasma Lipids in Patients With Surgically Resected Early Breast CancerJournal of Clinical Oncology, 2005
- Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral FracturesResults From the Fracture Intervention TrialJAMA, 1998
- Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fracturesThe Lancet, 1996
- Oestrogen and bone densityNuclear Medicine Communications, 1995